Eva Sum
4PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 16, 2022
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation.Eva Sum, Moritz Rapp, Harald Dürr
|Apr 27, 2021
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors.Sara Labiano, Vincent Roh, Céline Godfroid
|Mar 27, 2021
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity.Eva Sum, Moritz Rapp, Philipp Fröbel
|Mar 13, 2020
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy.Maud Mayoux, Andreas Roller, Vesna Pulko
Pageof 1
Frequent Collaborators
2 joint publications
Mario Perro
2 joint publications
Pedro Romero
1 joint publications
Maud Mayoux
1 joint publications
Stefano Sammicheli
1 joint publications
Christian Jost
1 joint publications
Marieke F Fransen
1 joint publications
Ines Matos
1 joint publications
Anton Belousov
1 joint publications
Daniel S Chen
1 joint publications
Pablo Umana
